Inotuzumab ozogamicin and Moxetumomab pasudotox-tdfk Intravenous
Determining the interaction of Inotuzumab ozogamicin and Moxetumomab pasudotox-tdfk Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: inotuzumab ozogamicin
Brand name: Besponsa
Synonyms: Inotuzumab Ozogamicin
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab pasudotox, Moxetumomab Pasudotox
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Inotuzumab ozogamicin-Moxifloxacin
- Inotuzumab ozogamicin-Moxifloxacin (Systemic)
- Inotuzumab ozogamicin-Moxifloxacin Hydrochloride
- Inotuzumab ozogamicin-Moxifloxacin Injection
- Inotuzumab ozogamicin-Moxifloxacin Intravenous
- Inotuzumab ozogamicin-Moxifloxacin Tablets
- Moxetumomab pasudotox-tdfk Intravenous-Inotuzumab ozogamicin Intravenous
- Moxetumomab pasudotox-tdfk Intravenous-Inova
- Moxetumomab pasudotox-tdfk Intravenous-Inova 4/1 topical
- Moxetumomab pasudotox-tdfk Intravenous-Inova 8/2 topical
- Moxetumomab pasudotox-tdfk Intravenous-Inova ACT
- Moxetumomab pasudotox-tdfk Intravenous-Inrebic